The 21st edition of Sustainability Through Science and Technology Summit 2025 (SIPS 2025), dedicated to Prof. Aaron Ciechanover, Nobel Laureate in Chemistry,…
Over 6 million Americans are impacted by Alzheimer’s disease, and researchers from Vanderbilt University Medical Center and the University of Pittsburgh are discovering how lifestyle…
Since becoming only the second Alzheimer’s-modifying drug to gain American Federal Drug Administration approval in 2023, sales of lecanemab, known…
Researchers from Cleveland Clinic’s Genome Center outlined the pathway human herpes simplex virus-1 (HSV1) can use to contribute to Alzheimer’s…
A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway…
In a groundbreaking theory, scientists at Arizona State University’s Biodesign Institute propose a unifying explanation for the molecular chaos driving…
Scientists led by the Institute of Nanotechnology in Italy, in collaboration with the ESRF, the European Synchrotron in Grenoble, France,…
Scientists have recently shown that both the quality and the amount of sleep we get may influence our risk of…
Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical mechanism that…
New research published by a team of researchers from the University of Toronto in collaboration with colleagues from the University…
Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products can offer hints…
Playing a single 18-hole round of golf or completing 6 km of either Nordic walking or regular walking may significantly…
Prion diseases came to public attention during the 1980s and ’90s, when Mad Cow Disease was in the news. While…
Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of…
Weill Cornell Medicine investigators have found that two genetic variants that confer high risk of Alzheimer’s disease (AD) together trigger…
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For…
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer’s disease, and improve…
People with Down syndrome are likely to develop Alzheimer’s disease at a young age, with autopsy studies showing that by…
Older age, female sex, irregular heart rhythms, and daily activity levels can help to predict how much Alzheimer’s Disease patients’…
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early…
Ten million new cases of dementia are diagnosed each year but the presence of different dementia forms and overlapping symptoms…
An international panel of experts led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la…
Research in nonhuman primates is opening the possibility of testing treatments for the early stages of Alzheimer’s and similar diseases,…
Certain drugs used to treat urinary symptoms due to an enlarged prostate may be associated with a reduced risk of…
Prions are the abnormal, pathogenic agents that are transmissible and are able to induce abnormal folding of specific normal cellular…
People who give birth to infants less than 5.5 pounds may be more likely to have memory and thinking problems…
A new paper in Trends in Pharmacological Sciences from researchers at generative artificial intelligence (AI)- and robotics-powered clinical stage drug…
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer’s disease research by…
A University of Kansas study of rare gene mutations that cause hereditary Alzheimer’s disease shows these mutations disrupt production of…
Researchers at the University of Houston Andy & Barbara Gessner College of Nursing have published a systematic approach to re-designing a…